Drug intelligence / Profile preview

moxaverine

Development stage
Phase 3
Lead developer
URSAPHARM Arzneimittel
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Moxaverine is a synthetic small molecule vasodilator and a derivative of papaverine. It acts primarily as a phosphodiesterase inhibitor, leading to smooth muscle relaxation and vasodilation. Moxaverine also improves the rheological properties of red blood cells, enhancing microcirculatory blood flow. Clinically, it has been used to increase ocular blood flow in conditions such as age-related macular degeneration and primary open angle glaucoma, and has been studied for its effects on ischemia and other vascular disorders[1][4][5]. Its mechanism involves inhibition of phosphodiesterase enzymes, which increases intracellular cyclic nucleotide levels (cAMP/cGMP), resulting in smooth muscle relaxation[1][5]. Moxaverine hydrochloride is marketed under the brand name Kollateral forte.

Brand names
Kollateral forte
Other names
moxaverine hydrochloride
02

Targets

PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on moxaverine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on moxaverine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call